Wardlaw A J, Walsh G M, Symon F A
Department of Respiratory Medicine, Leicester University School of Medicine, Glenfield Hospital, UK.
Allergy. 1994 Dec;49(10):797-807. doi: 10.1111/j.1398-9995.1994.tb00778.x.
Considerable progress has been made in our understanding of the molecular mechanisms involved in eosinophil and basophil migration into sites of allergic inflammation. It is clearly a staged process, each stage offering a level of control over the cell specificity and degree of migration. On the basis of current evidence, the various receptors and mediators involved are summarized in Table 4. Once in the tissues, eosinophils may persist for several days or weeks, surviving under the influence of locally generated cytokines, and this persistence may also partly explain the selective tissue accumulation of eosinophils and basophils. Understanding the molecular mechanisms involved in leukocyte migration may lead to the discovery of selective and effective antagonists to treat allergic disease by preventing cell migration. Results in a number of animal models already suggest that this approach may be successful. The development of drugs that can be tested in the clinic is awaited with much interest.
在我们对嗜酸性粒细胞和嗜碱性粒细胞迁移至变应性炎症部位所涉及的分子机制的理解方面已经取得了相当大的进展。这显然是一个分阶段的过程,每个阶段都对细胞特异性和迁移程度提供一定程度的控制。根据目前的证据,表4总结了所涉及的各种受体和介质。一旦进入组织,嗜酸性粒细胞可能会持续存在数天或数周,在局部产生的细胞因子的影响下存活,这种持续性也可能部分解释了嗜酸性粒细胞和嗜碱性粒细胞在组织中的选择性积聚。了解白细胞迁移所涉及的分子机制可能会导致发现选择性和有效的拮抗剂,通过阻止细胞迁移来治疗变应性疾病。一些动物模型的结果已经表明这种方法可能是成功的。人们非常期待能够在临床上进行测试的药物的开发。